Clinical Trial Update: Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated LDL apheresis using H.E.L.P. therapy for familial hypercholesterolemia; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• H.E.L.P. Therapy

Snippet

Sponsor: B. Braun Medical Inc. | Conditions: Familial Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2014-01-29